EUVIMEDEUVIMED entdecken
Open Access

Decellularized Extracellular Matrix Mitigates the Senescent Phenotype and Restores Osteogenic Potential in Human Mesenchymal Stromal Cells

Connor J Dorais iD, Nikolia M Kruger iD, David H Ramos-Rodriguez iD, Mark A Lee iD, J Kent Leach iD

Journal of Orthopaedic Research · 2026

DOI: 10.1002/jor.70264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2026. Verfasst von Connor J Dorais und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, UC Davis Health, Sacramento, California, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteogenesis, Cellular Senescence, Decellularized Extracellular Matrix. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autologous cell‐based approaches for bone repair using mesenchymal stromal cells (MSCs) in older patients are limited in part by cellular senescence, resulting in impaired MSC self‐renewal and differentiation. Currently, the field lacks a standardized method to induce senescence in human MSCs and characterize them for experimental use, as well as effective strategies to mitigate the harmful effects of the senescence‐associated secretory phenotype (SASP). We previously demonstrated that MSC‐secreted decellularized extracellular matrix (dECM) enhances the osteogenic potential and survival of MSCs. We hypothesized that senescent MSCs would exhibit improved osteogenic potential and reduced SASP activity when maintained on dECM. We first demonstrated that a senescent phenotype can be reliably induced in human MSCs through ionizing irradiation coupled with a 21‐day preconditioning phase in culture, evidenced by increased beta‐galactosidase staining and enlarged cell area. We then observed that senescent MSCs on dECM exhibit improved osteogenic potential and reduced SASP compared to cells on tissue culture plastic, evidenced by quantifying markers of osteogenic differentiation and ELISAs for known inflammatory cytokines. These data support the promise of dECM as an instructive biomaterial to enhance the regenerative potential of MSCs from older patients for autologous bone repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsOsteogenesisCellular SenescenceDecellularized Extracellular MatrixExtracellular MatrixHumansCell DifferentiationCells, CulturedPhenotypeSenescence-Associated Secretory Phenotype

Stichwörter der Autor:innen

boneextracellular matrixmesenchymal stromal cellsosteogenesissenescence

Substanzen

Decellularized Extracellular Matrix

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, UC Davis Health, Sacramento, California, USA.
  • Department of Biomedical Engineering, University of California, Davis, Davis, California, USA.

ORCID-Profile: Connor J Dorais, Nikolia M Kruger, David H Ramos-Rodriguez, Mark A Lee, J Kent Leach

Zitieren

APA

Dorais, C. J., Kruger, N. M., Ramos-Rodriguez, D. H., Lee, M. A., & Kent Leach, J. (2026). Decellularized Extracellular Matrix Mitigates the Senescent Phenotype and Restores Osteogenic Potential in Human Mesenchymal Stromal Cells. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.70264

Vancouver

Dorais CJ, Kruger NM, Ramos-Rodriguez DH, Lee MA, Kent Leach J. Decellularized Extracellular Matrix Mitigates the Senescent Phenotype and Restores Osteogenic Potential in Human Mesenchymal Stromal Cells. Journal of Orthopaedic Research. 2026. doi:10.1002/jor.70264

BibTeX
@article{Dorais2026,
  author = {Dorais, Connor J and Kruger, Nikolia M and Ramos-Rodriguez, David H and Lee, Mark A and Kent Leach, J},
  title = {Decellularized Extracellular Matrix Mitigates the Senescent Phenotype and Restores Osteogenic Potential in Human Mesenchymal Stromal Cells},
  journal = {Journal of Orthopaedic Research},
  year = {2026},
  doi = {10.1002/jor.70264}
}
Kostenlos starten →